WHO ICTRP trial
Clinical efficacy of NMDA receptor glycine binding site-targeted drugs to…
ChiCTR2500095767 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2500095767 |
|---|---|
| Public title | Clinical efficacy of NMDA receptor glycine binding site-targeted drugs to enhance the antidepressant efficacy of iTBS |
| Scientific title | Clinical efficacy of NMDA receptor glycine binding site-targeted drugs to enhance the antidepressant efficacy of iTBS |
| Primary sponsor | Linyi Mental Health Center (Linyi Fourth People's Hospital) |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 1-2 |
| Countries | China |
| Conditions | depressive disorder |
| Interventions | Control group:Placebo and high frequency iTBS antidepressant treatment;Dextrocycloserine group:D-Cycloserine and high-frequency iTBS antidepressant treatment;Dextro-serine group:D-serine and high-frequency iTBS antidepressant… |
| Registration date | Jan 13, 2025 |
| Target size | Control group:30;Dextrocycloserine group:30;Dextro-serine group:30;L-leucine… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: